Loxitane

Active Ingredient(s): Loxapine
FDA Approved: * February 25, 1975
Pharm Company: * WATSON LABS
Category: Antipsychotic

Loxapine, sold under the brand names Loxitane and Adasuve (inhalation only) among others, is an antipsychotic medication used primarily in the treatment of schizophrenia. The drug is a member of the dibenzoxazepine class and structurally related to clozapine. Several researchers have argued that loxapine, initially classified as a typical antipsychotic, behaves as an atypical antipsychotic.[2] Loxapine may be metabolized by N-demethylation to amoxapine, a tricyclic antidepress... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Loxitane 5 mg Oral Capsule
NDC: 52544-494
Labeler:
Watson Pharma, Inc.
Loxitane 10 mg Oral Capsule
NDC: 52544-495
Labeler:
Watson Pharma, Inc.
Loxitane 25 mg Oral Capsule
NDC: 52544-496
Labeler:
Watson Pharma, Inc.
Loxitane 50 mg Oral Capsule
NDC: 52544-497
Labeler:
Watson Pharma, Inc.